Cargando…
Phosphorylated-Akt overexpression is associated with a higher risk of brain metastasis in patients with non-small cell lung cancer
Brain metastasis (BM) of non-small cell lung cancer (NSCLC) is relatively common and has a poor prognosis. Moreover, identifying which patients are more likely to develop BM is challenging. Akt, a serine/threonine-specific protein kinase, can be activated in various tumors, including lung cancer, an...
Autores principales: | Jin, Yu, Yuan, Ye, Yi, Minxiao, Han, Hu, Liu, Bo, Li, Qianxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444023/ https://www.ncbi.nlm.nih.gov/pubmed/30976664 http://dx.doi.org/10.1016/j.bbrep.2019.100625 |
Ejemplares similares
-
SNPs in the TGF-β Signaling Pathway Are Associated with Increased Risk of Brain Metastasis in Patients with Non–Small-Cell Lung Cancer
por: Li, Qianxia, et al.
Publicado: (2012) -
Advances in Lung Cancer Driver Genes Associated With Brain Metastasis
por: Kang, Yalin, et al.
Publicado: (2021) -
KIT Mutations Correlate with Higher Galectin Levels and Brain Metastasis in Breast and Non-Small Cell Lung Cancer
por: Funkhouser, Avery T., et al.
Publicado: (2022) -
The Prognostic Value of Phosphorylated AKT Expression in Non-Small Cell Lung Cancer: A Meta-Analysis
por: Qiu, Zhi-Xin, et al.
Publicado: (2013) -
Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer
por: Li, Qing, et al.
Publicado: (2022)